Last reviewed · How we verify
Relapsing multiple sclerosis
Approved treatments
- Imuran · Legacy Pharma
- Arzerra · Glaxo Grp Ltd
Arzerra works by binding to the CD20 protein on B cells, marking them for destruction by the immune system. - Arzerra · GlaxoSmithKline
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Relapsing multiple sclerosis patent landscape — cliff calendar, originator estates, attackable patents
- Relapsing multiple sclerosis treatment landscape brief
- Relapsing multiple sclerosis treatment updates RSS
Frequently asked questions about Relapsing multiple sclerosis
What drugs treat Relapsing multiple sclerosis?
Tracked treatments include Imuran, Arzerra.
What is the treatment for Relapsing multiple sclerosis?
Standard treatment for Relapsing multiple sclerosis includes Imuran, Arzerra. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Relapsing multiple sclerosis patent cliff · Relapsing multiple sclerosis CI report
- Treatment: Imuran · Legacy Pharma
- Treatment: Arzerra · Glaxo Grp Ltd
- Treatment: Arzerra · GlaxoSmithKline
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing